Skip to content
Recall Observatory FDA recall evidence

Drug product

mitoXANTRONE Injection USP (concentrate), 20 mg/10 mL (2 mg/mL), 10 mL Multiple Dose Vial, Rx only, Teva Parenteral Medicines, Inc., Irvine, CA 92618, NDC 0703-4685-01.

D-0095-2017

September 13, 2016

Class III

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 75236
Status
Terminated
Classification
Class III
Quantity
11,214 vials
Official record key
drug-enforcement:D-0095-2017

Official wording

Reason: Failed Impurities/Degradation Specifications: potential failure to meet the specification for Impurity D throughout shelf-life.

Code information: Lot Numbers: 31318574B, Exp 09/16; 31319610B, Exp 07/17; 31320058B, Exp 11/17; 31320497B, Exp 12/17; 31320744B, Exp 02/18

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications